Daily non-political popular news in brief.

Treatment-induced growth factor causes cancer progression

A research team at the Vanderbilt-Ingram Cancer Center, led by Carlos Arteaga, M.D., reports in the May issue of the Journal of Clinical Investigation that radiation and chemotherapy increase circulating levels of the growth factor TGF-beta, circulating cancer cells, and tumor metastases in a mouse model of metastatic breast cancer.

Read more »

Keywords: treatment-induced, growth, factor, causes, cancer, progression, treatment, induced, cause

« Previous | Next »

Similar news on "Treatment-induced growth factor causes cancer progression":

1. Alzheimer's enzyme acts as a tumor suppressor
   06-07-2007 · EurekAlert!
   Researchers at Burnham Institute for Medical Research ("Burnham") have provided the first evidence that gamma-secretase, an enzyme key to the progression of Alzheimer's, acts as a tumor suppressor by altering the pathway of epidermal growth factor receptor (EGFR), a potential treatment target for cancer. Expedited to publication online by Proceedings of the National Academy of Sciences, these findings reveal a limitation of targeting gamma-secretase for treatment of Alzheimer's and potentially other diseases.
   Similar news · Read more »
   
2. Growth factor signals influence balance between normal growth and cancerous growth
   11-09-2006 · EurekAlert!
   Too much of a signaling protein called insulin-like growth factor-I (IGF-I) may fan the flames of cancer, while too little of the protein may cause short stature, dementia and osteoporosis. New research investigates how the growth hormone/IGF system is affected by the important tumor suppressor gene p53. This interplay of two signaling pathways reinforces questions about the long-term risks of prescribing growth hormone, while suggesting a future new avenue for cancer therapy.
   Similar news · Read more »
   
3. RNA splicing factor implicated in ovarian tumor cell growth
   04-09-2007 · EurekAlert!
   An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago.
   Similar news · Read more »
   
4. Electric fields have potential as a cancer treatment
   08-02-2007 · EurekAlert!
   Low-intensity electric fields can disrupt the division of cancer cells and slow the growth of brain tumors, suggest laboratory experiments and a small human trial, raising hopes that electric fields will become a new weapon for stalling the progression of cancer. The August 2007 issue of Physics Today describes the mechanisms by which the electric fields do their work.
   Similar news · Read more »
   
5. Role of TRPM8 in the development of prostate cancer
   05-17-2007 · EurekAlert!
   In normal prostate epithelium, cells coexist in many stages of development-differentiation, and disrupted differentiation and proliferation are major causes of cancer. A new study shows that the endoplasmic reticulum protein TRPM8 (ER-TRPM8) present in human prostate epithelial luminal cancer cells retains it’s function as a calcium release channel, independent of the differentiation state of the cell, and may be an important factor in controlling the growth of prostate cancer cells.
   Similar news · Read more »
   
6. Gene variation may elevate risk of liver tumor in patients with cirrhosis
   01-01-2008 · EurekAlert!
   A particular gene variation appears to significantly increase the risk that individuals with cirrhosis of the liver will go on to develop hepatocellular carcinoma, a liver tumor that is the third leading cause of cancer death. Researchers from Massachusetts General Hospital Cancer Center and colleagues in France have found that a single alteration in the epidermal growth factor gene may greatly increase the risk that cirrhotic patients will develop the tumor.
   Similar news · Read more »
   
7. New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer
   02-16-2007 · EurekAlert!
   A new class of targeted anti-cancer drugs that blocks the human epidermal growth factor (HER) receptor family shows promise in prolonging the lives of patients with recurrent prostate cancer, a new Cedars-Sinai study shows.
   Similar news · Read more »
   
8. Mistletoe is not an anti-cancer drug, say doctors
   12-21-2006 · EurekAlert!
   The belief that mistletoe can help treat cancer is a myth which can cause harm, warn doctors in this week's Christmas issue of the BMJ.The warning follows the case of a cancer patient who attended hospital with a tumour-like growth under the skin induced by mistletoe.
   Similar news · Read more »
   
9. Therapeutic unshackles p53 and causes tumor regression
   03-15-2007 · EurekAlert!
   Infection with Kaposi's sarcoma virus (KSHV) can cause 3 types of tumor, including primary effusion lymphoma (PEL). Although KSHV has been known to cause tumors for many years, there are no effective therapies for KSHV-induced tumors. In a new study it is shown that the small-molecule inhibitor Nutlin-3a has antitumor effects in a mouse xenograft model of PEL, indicating that it might provide a viable therapeutic option for the treatment of individuals with PEL.
   Similar news · Read more »
   
10. Growth factor receptor affects prostate cancer progression
    12-10-2007 · EurekAlert!
    Breeding mice with a gene for a cellular receptor that can be turned on and off-at will-not only enabled researchers at Baylor College of Medicine in Houston to show how prostate cancer progresses, but also provides a model for studying when a drug targeting a gene will have an effect on the cancer.
    Similar news · Read more »